Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in M&A / Deals

Shionogi secures $482m BARDA contract to tackle AMR crisis

 April 9, 2026

Pharmaceutical Technology

Shionogi will use the money from BARDA to build an American antibiotic manufacturing site as the US looks to fight antimicrobial resistance.

M&A / DealsInfectious DiseaseRead full story

Post navigation

Sidewinder secures $137M to advance ‘precision’ ADCs →
← Syneron raises $150m for macrocyclics, and other financings

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com